Since SPI1 is essential for LSC formation and SPI1 expression is regulated and maintained by the β-catenin-SPI1-HAVCR2 regulatory circuit, we hypothesized that cotargeting any component of this circuit with an anti-PI3K inhibitor may effectively eliminate existing T-ALL cells. Here, SPI1 is linked to acute lymphoblastic leukemia.